vs
Gogo Inc.（GOGO）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Gogo Inc.的季度营收约是再鼎医药的1.8倍（$230.6M vs $127.1M），Gogo Inc.同比增速更快（67.3% vs 17.1%），Gogo Inc.自由现金流更多（$-25.4M vs $-26.7M），过去两年Gogo Inc.的营收复合增速更高（48.7% vs 20.8%）
Gogo Inc.是美国公务机机载宽带互联网及连接服务提供商，总部位于科罗拉多州布鲁姆菲尔德。截至目前，已有超过2500架商用飞机和6600架公务机安装了该公司的机载Wi-Fi服务。该公司曾面向民航业提供机上WiFi服务，2020年12月已将这块民航业务以4亿美元出售给国际通信卫星组织。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
GOGO vs ZLAB — 直观对比
营收规模更大
GOGO
是对方的1.8倍
$127.1M
营收增速更快
GOGO
高出50.2%
17.1%
自由现金流更多
GOGO
多$1.3M
$-26.7M
两年增速更快
GOGO
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $230.6M | $127.1M |
| 净利润 | $-10.0M | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 6.2% | -54.6% |
| 净利率 | -4.3% | — |
| 营收同比 | 67.3% | 17.1% |
| 净利润同比 | 64.6% | — |
| 每股收益（稀释后） | $-0.08 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GOGOZLAB
| Q4 25 | $230.6M | $127.1M | ||
| Q3 25 | $223.6M | $115.4M | ||
| Q2 25 | $226.0M | $109.1M | ||
| Q1 25 | $230.3M | $105.7M | ||
| Q4 24 | $137.8M | $108.5M | ||
| Q3 24 | $100.5M | $101.8M | ||
| Q2 24 | $102.1M | $100.1M | ||
| Q1 24 | $104.3M | $87.1M |
净利润GOGOZLAB
| Q4 25 | $-10.0M | — | ||
| Q3 25 | $-1.9M | $-36.0M | ||
| Q2 25 | $12.8M | $-40.7M | ||
| Q1 25 | $12.0M | $-48.4M | ||
| Q4 24 | $-28.2M | — | ||
| Q3 24 | $10.6M | $-41.7M | ||
| Q2 24 | $839.0K | $-80.3M | ||
| Q1 24 | $30.5M | $-53.5M |
毛利率GOGOZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | 87.8% | 60.6% | ||
| Q1 25 | 87.3% | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率GOGOZLAB
| Q4 25 | 6.2% | -54.6% | ||
| Q3 25 | 12.9% | -42.3% | ||
| Q2 25 | 15.9% | -50.3% | ||
| Q1 25 | 15.3% | -53.3% | ||
| Q4 24 | -17.5% | -62.6% | ||
| Q3 24 | 19.0% | -66.6% | ||
| Q2 24 | 21.2% | -76.0% | ||
| Q1 24 | 33.2% | -80.7% |
净利率GOGOZLAB
| Q4 25 | -4.3% | — | ||
| Q3 25 | -0.9% | -31.2% | ||
| Q2 25 | 5.7% | -37.3% | ||
| Q1 25 | 5.2% | -45.8% | ||
| Q4 24 | -20.5% | — | ||
| Q3 24 | 10.6% | -40.9% | ||
| Q2 24 | 0.8% | -80.2% | ||
| Q1 24 | 29.2% | -61.4% |
每股收益（稀释后）GOGOZLAB
| Q4 25 | $-0.08 | $-0.05 | ||
| Q3 25 | $-0.01 | $-0.03 | ||
| Q2 25 | $0.09 | $-0.04 | ||
| Q1 25 | $0.09 | $-0.04 | ||
| Q4 24 | $-0.22 | $-0.09 | ||
| Q3 24 | $0.08 | $-0.04 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $0.23 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $101.1M | $715.5M |
| 总资产 | $1.3B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GOGOZLAB
| Q4 25 | $125.2M | $689.6M | ||
| Q3 25 | $133.6M | $717.2M | ||
| Q2 25 | $102.1M | $732.2M | ||
| Q1 25 | $70.3M | $757.3M | ||
| Q4 24 | $41.8M | $779.7M | ||
| Q3 24 | $176.7M | $616.1M | ||
| Q2 24 | $161.6M | $630.0M | ||
| Q1 24 | $152.8M | $650.8M |
股东权益GOGOZLAB
| Q4 25 | $101.1M | $715.5M | ||
| Q3 25 | $107.0M | $759.9M | ||
| Q2 25 | $102.8M | $791.7M | ||
| Q1 25 | $82.9M | $810.8M | ||
| Q4 24 | $69.3M | $840.9M | ||
| Q3 24 | $52.7M | $667.7M | ||
| Q2 24 | $52.0M | $704.2M | ||
| Q1 24 | $62.4M | $762.2M |
总资产GOGOZLAB
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.2B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $810.7M | $985.3M | ||
| Q2 24 | $802.7M | $987.4M | ||
| Q1 24 | $809.0M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.5M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-25.4M | $-26.7M |
| 自由现金流率自由现金流/营收 | -11.0% | -21.0% |
| 资本支出强度资本支出/营收 | 14.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $65.1M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流GOGOZLAB
| Q4 25 | $8.5M | $-26.0M | ||
| Q3 25 | $46.8M | $-32.0M | ||
| Q2 25 | $36.7M | $-31.0M | ||
| Q1 25 | $32.5M | $-61.7M | ||
| Q4 24 | $-38.3M | $-55.8M | ||
| Q3 24 | $25.1M | $-26.8M | ||
| Q2 24 | $24.9M | $-42.2M | ||
| Q1 24 | $29.7M | $-90.1M |
自由现金流GOGOZLAB
| Q4 25 | $-25.4M | $-26.7M | ||
| Q3 25 | $27.3M | $-35.0M | ||
| Q2 25 | $33.5M | $-33.9M | ||
| Q1 25 | $29.7M | $-63.2M | ||
| Q4 24 | $-42.6M | $-58.4M | ||
| Q3 24 | $20.7M | $-28.2M | ||
| Q2 24 | $21.6M | $-42.9M | ||
| Q1 24 | $28.2M | $-91.1M |
自由现金流率GOGOZLAB
| Q4 25 | -11.0% | -21.0% | ||
| Q3 25 | 12.2% | -30.4% | ||
| Q2 25 | 14.8% | -31.1% | ||
| Q1 25 | 12.9% | -59.9% | ||
| Q4 24 | -30.9% | -53.8% | ||
| Q3 24 | 20.6% | -27.7% | ||
| Q2 24 | 21.1% | -42.9% | ||
| Q1 24 | 27.0% | -104.5% |
资本支出强度GOGOZLAB
| Q4 25 | 14.7% | 0.5% | ||
| Q3 25 | 8.7% | 2.6% | ||
| Q2 25 | 1.4% | 2.6% | ||
| Q1 25 | 1.2% | 1.5% | ||
| Q4 24 | 3.1% | 2.4% | ||
| Q3 24 | 4.4% | 1.3% | ||
| Q2 24 | 3.3% | 0.7% | ||
| Q1 24 | 1.4% | 1.1% |
现金转化率GOGOZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.87× | — | ||
| Q1 25 | 2.70× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 29.74× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GOGO
| Services | $191.9M | 83% |
| Products | $38.7M | 17% |
| Fcc Reimbursement Program | $2.0M | 1% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
